MHRA Medical License X | FDA Approval X

Dutasteride (Avodart) takes effect similarly to the male pattern hair loss treatment finasteride 1mg by inhibiting the formation of DHT. As DHT is the fundamental cause of genetic hair loss, blocking its formation is known to be one of the most effective ways to prevent male pattern hair loss.

As Dutasteride (Avodart) has not been licensed by the MHRA or FDA approved for the prevention of hair loss, Belgravia does not prescribe this medication. The MHRA and FDA are medical regulatory bodies in the UK and USA respectively and if they have not issued a medical license for a product there is no way to know whether it is effective or safe to use.

When measuring side effects, and the time they take to leave one’s system, the term used is ‘half-life’. The half life of a product is the time that it takes for the product to decrease to half the amount in one’s body since the time the product was taken. Reports state that Dutasteride (Avodart) has a half-life of over 240 hours. This means that if you take 5mg of Dutasteride, 240 hours later you will still have 2.5mg of Dutasteride in your body, and 1.25mg, 240 hours after that. After 1 month there will still be 0.625mg present in your body.

Until Dutasteride is licensed as a hair loss product, The Belgravia Centre will not offer this as part of their treatment programmes. For more information on the course components currently available from The Belgravia Centre visit our HAIR LOSS TREATMENT pages.


Belgravia Consultations

Submit an instant online consultation so that one of Belgravia’s hair loss specialists can diagnose your condition and recommend an effective course of treatment, wherever you live. Or, arrange a free consultation at one of our Central London clinics.